The invention discloses a coronary
artery thrombolytic agent for acute
myocardial infarction. The coronary
artery thrombolytic agent is prepared from, by weight, 0.5-2 parts of tirofiban, 5-10 parts of
bivalirudin, 3-5 parts of tenecteplase, 0.4 part of
sodium nitroprusside, 0.0032 part of unfractionated
heparin and the balance normal
saline, and the normal
saline is used for diluting the mixture to obtain the volume which is 10 times of the original volume. Researches show that great advantages are brought when antiplatelet and
anticoagulant drugs are administrated in a coronary
artery based on PCI treatment, local
drug concentration is high according to
drug administration in the coronary, the needed
thrombolytic drug dosage is small,
thrombolysis is fast, the success rate is high, and few of hemorrhagic complications are caused. The coronary artery
thrombolytic agent is used in cooperation with the intranperative
radiography or intracavity radiological technology,
thrombus changes can be dynamically monitored in real time, the best microthrombus dissolving effect is achieved, the PCI intraoperative no-reflow occurrence rate is lowered, and the prognosis of a patient is significantly improved.